ATALAR, B. Et Al. 2018. Medically Inoperable Early-Stage Lung Cancer Treated with Stereotactic Ablative Radiation Therapy (SABR): Multicenter Study of Turkish Radiation Oncology Group (TRO. ASTRO , (United States Of America), 671-672.

ATALAR, B., KAYTAN SAĞLAM, E., AKGÜN, Z., Abacıoğlu, U., ŞAHİN, B., ÖZYAR, E., ... Özşeker, N.(2018). Medically Inoperable Early-Stage Lung Cancer Treated with Stereotactic Ablative Radiation Therapy (SABR): Multicenter Study of Turkish Radiation Oncology Group (TRO . ASTRO (pp.671-672). , United States Of America

ATALAR, BANU Et Al. "Medically Inoperable Early-Stage Lung Cancer Treated with Stereotactic Ablative Radiation Therapy (SABR): Multicenter Study of Turkish Radiation Oncology Group (TRO," ASTRO, United States Of America, 2018

ATALAR, BANU Et Al. "Medically Inoperable Early-Stage Lung Cancer Treated with Stereotactic Ablative Radiation Therapy (SABR): Multicenter Study of Turkish Radiation Oncology Group (TRO." ASTRO , United States Of America, pp.671-672, 2018

ATALAR, B. Et Al. (2018) . "Medically Inoperable Early-Stage Lung Cancer Treated with Stereotactic Ablative Radiation Therapy (SABR): Multicenter Study of Turkish Radiation Oncology Group (TRO." ASTRO , United States Of America, pp.671-672.

@conferencepaper{conferencepaper, author={BANU ATALAR Et Al. }, title={Medically Inoperable Early-Stage Lung Cancer Treated with Stereotactic Ablative Radiation Therapy (SABR): Multicenter Study of Turkish Radiation Oncology Group (TRO}, congress name={ASTRO}, city={}, country={United States Of America}, year={2018}, pages={671-672} }